TrialAnnals of oncology : official journal of the European Society for Medical Oncology2014

Survival follow-up and ipilimumab retreatment of patients with advanced melanoma who received ipilimumab in prior phase II studies.

C Lebbé et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.